Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients - study protocol for a randomized controlled trial.
Alexandra HalalauDaniel SheldenScott KeeneyJaspreet HeharPublished in: Trials (2018)
ClinicalTrials.gov, ID: NCT03377127 . Protocol version: registered on 10 February 2018; version #1.
Keyphrases
- phase ii study
- type diabetes
- open label
- end stage renal disease
- cardiovascular disease
- ejection fraction
- glycemic control
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- psychometric properties
- double blind
- peritoneal dialysis
- prognostic factors
- locally advanced
- molecular dynamics
- squamous cell carcinoma
- clinical trial
- radiation therapy
- skeletal muscle
- patient reported outcomes